Chronic Thromboembolic Pulmonary Hypertension Soluble Guanylate Cyclase–Stimulator Trial 1 - CHEST-1

Description:

Chronic thromboembolic pulmonary hypertension (CTEPH) is very difficult to treat. The gold standard has been pulmonary thromboendarterectomy, but is offered at very few centers. Although currently available pulmonary vasodilators are sometimes used in this condition, there are no approved medications available for this condition. Riociguat is a novel pulmonary vasodilator that acts via stimulation of soluble guanylate cyclase (sGC). The current trial sought to study the safety and efficacy of ri...